To assess the role of glycocalyx production in the pathogenesis of endocarditis caused by viridans group streptococci in adult patients, glycocalyx production was examined for 49 blood culture isolates. The tryptophan assay, a quantitative spectrophotometric test, was used to measure cell-adherent glycocalyx production. Absorbance values of the isolates that produced endocarditis were significantly higher (means, 0.166 versus 0.060 [P < 0.001]). At a breakpoint of absorbance of 0.120, the sensitivity of the test was 0.83, the specificity was 0.96, and the predictive value was 0.95. These data suggest that the in vitro tryptophan assay of glycocalyx production by viridans group streptococci has potential value as a predictor of clinical pathogenicity.
Streptococci are the leading cause of bacterial endocarditis, accounting for about 45% of all cases. Of these, at least 75% are caused by viridans group streptococci (15) . The interaction between these microorganisms and the damaged heart valve (nonbacterial thrombotic endocarditis) is a crucial step in the development of endocarditis. The ability of viridans group streptococci to adhere to damaged heart valves partially explains the high incidence of endocarditis. Gould et al. demonstrated that the organisms that frequently cause endocarditis (e.g., enterococci, viridans group streptococci, Staphylococcus aureus, and Staphylococcus epidermidis) adhere to valvular endothelium significantly better than organisms that rarely cause endocarditis (5). Pelletier et al. reported that the viridans group streptococci which produce dextran (glycocalyx) have a higher likelihood of producing endocarditis in the rabbit model (11) . Preincubation of these isolates with the enzyme dextranase, which digests glycocalyx, markedly inhibited the abiity of these organisms to initiate the infection (1). Parker and Ball have noted that some members of the viridans group streptococcal family are more likely to be responsible for endocarditis (Streptococcus mutans, Streptococcus mitior, and Streptococcus sanguis). These organisms all produce abundant glycocalyx (10) . Studies in our laboratory have shown that the amount of glycocalyx produced is correlated with the size of infected cardiac vegetations and resistance to antimicrobial therapy (12) . These relationships have commonly been measured by qualitative light microscopy assays with the polysaccharide stains ruthenium red, periodic acid-Schiff, and Cellufluor (7). To further study the role of glycocalyx in endocarditis pathogenesis, we reported a quantitative spectrophotometric assay which measures cell adherent glycocalyx produced by viridans group streptococci grown in glucose substrate (2) . The assay is based on the tryptophan reaction described by Shetlar et al. (13) . This assay has shown correlation between the amount of cell-adherent glycocalyx, the size of the cardiac vegetation in vivo, and the ability to sterilize the streptococci with antibiotics (2). The investigation described below looks at the ability of this in vitro assay to predict the (3) .
RESULTS
Of the 49 patient isolates, 24 were judged to be endocarditis producing according to the scheme of Von Reyn et al. (14) ASSOCIATION OF GLYCOCALYX AND ENDOCARDITIS (Table 1 ). Figure 1 shows the tryptophan assay results for the 49 isolates (24 endocarditis-producing strains and 25 nonendocarditis-producing strains). The mean absorbance of the endocarditis-producing group was significantly different from that of the nonendocarditis group (P < 0.001). The breakpoint of A5oe (0.120) was established at >1 standard deviation from the means of the endocarditis (0.166 ± 0.045) and the nonendocarditis (0.060 ± 0.031) groups. Of the four patients with endocarditis and absorbance values less than 0.120, two belonged to the probable-endocarditis group and two belonged to the possible-endocarditis group. The three isolates from the possible-endocarditis group with fever and at least two positive blood cultures without an extra cardiac source ( Table 1) had absorbances of 0.168 and greater. Table  2 demonstrates that the sensitivity of this assay was 0.83, the specificity was 0.96, and the predictive value was 0.95.
DISCUSSION
It is often difficult to correlate a positive blood culture with clinical pathogenicity. The physician has to decide whether the culture denotes infection, spontaneous bacteremia, or blood culture contamination. This is a larger problem in patients with underlying diseases for which clinical presentations may be atypical and in hospitalized patients who have undergone multiple invasive procedures. Laboratory markers can often aid in deciding the pathogenic potential of a blood culture isolate. Exopolysaccharide (slime) production of S. epidermidis has often correlated with pathogenicity (6) . The presence of teichoic acid antibody is advocated by some to correlate with serious S. aureus infections (9) .
Finding viridans group streptococci in the blood alerts the physician to the possibility of bacterial endocarditis. It is estimated that between 12 and 60% of patients with blood cultures positive for these organisms will have bacterial endocarditis (8) . This likelihood increases when there is underlying valvular heart disease (congenital or rheumatic). Some species of viridans group streptococci are more often responsible for endocarditis. In fact, blood cultures positive for S. mutans indicate endocarditis >90% of the time (10) . Unfortunately, it is extremely difficult for most laboratories to identify viridans group streptococci reproducibly. Some authorities report that it is not appropriate to even attempt this (4) because of variations among laboratories. The tryptophan assay may alleviate some of these problems. An isolate of viridans group streptococci with an absorbance of >0.120 has a high likelihood of causing endocarditis. For a given sensitivity and specificity, the predictive ability of a test decreases with decreasing prevalence of the disease. This is important for infrequent diseases like endocarditis, even with highly sensitive and specific tests. We recognize that the sensitivity and specificity data for the series of patients used in this study may not be as statistically The correlation of the cell-adherent polysaccharide with clinical pathogenicity gives a rationale for further investigating the character and nature of this bacterial glycocalyx.
